%0 Letter
%T Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.
%A Fu ZC
%A Cheng XG
%A Zhang GW
%A Shi RG
%A Zhang LJ
%A Sun HT
%A Huang JX
%J Int J Rheum Dis
%V 27
%N 5
%D 2024 May
%M 38736279
%F 2.558
%R 10.1111/1756-185X.15190